Flavonoid intake and the risk of cardiovascular disease in women

American Journal of Clinical Nutrition

Volumn 77, Issue 6, 2003, Pages 1400-1408

  Sesso, Howard D ^a,b,c,d   Gaziano, J Michael ^a,c   Liu, Simin ^a,b   Buring, Julie E ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c VA BOSTON HEALTHCARE SYSTEM   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Cardiovascular disease; Diet; Flavonoids; Nutrition; Primary prevention; Women

Indexed keywords

FLAVONE; FLAVONOID; FLAVONOL;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIETARY INTAKE; FEMALE; FOOD INTAKE; HEART INFARCTION; HUMAN; QUESTIONNAIRE; REVASCULARIZATION; SEX ROLE; STATISTICAL SIGNIFICANCE; APPLE; BRASSICA; DIET; FOLLOW UP; MIDDLE AGED; PROSPECTIVE STUDY; RISK; TEA;

BRASSICA OLERACEA VAR. BOTRYTIS; MALUS X DOMESTICA;

BRASSICA; CARDIOVASCULAR DISEASES; DIET; FEMALE; FLAVONOIDS; FOLLOW-UP STUDIES; HUMANS; MALUS; MIDDLE AGED; PROSPECTIVE STUDIES; RISK; TEA;

EID: 0037563937     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/77.6.1400     Document Type: Article

References (48)

1. Hollman PC, Katan MB Dietary flavonoids: intake, health effects and bioavailability. Food Chem Toxicol 1999;37:937-42.
2. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989;320:915-24.
3. de Whalley CV, Rankin SM, Hoult JR, Jessup W, Leake DS. Flavonoids inhibit the oxidative modification of low density lipoproteins by macrophages. Biochem Pharmacol 1990;39:1743-50.
4. Hollman PC, Hertog MG, Katan MB. Role of dietary flavonoids in protection against cancer and coronary heart disease. Biochem Soc Trans 1996;24:785-9.
5. Rimm EB, Katan MB, Ascheno A, Stampfer MJ, Willett WC Relation between intake of flavonoids and risk for coronary heart disease in male health professionals. Ann Intern Med 1996;125:384-9.
6. Yochum L, Kushi LH, Meyer K, Folsom AR. Dietary flavonoid intake and risk of cardiovascular disease in postmenopausal women. Am J Epidemiol 1999;149:943-9.
7. Hertog MG, Sweetnam PM, Fehily AM, Elwood PC, Kromhout D. Antioxidant flavonols and ischemic heart disease in a Welsh population of men: the Caerphilly Study. Am J Clin Nutr 1997;65: 1489-94.
8. Hirvonen T, Viriamo J, Korhonen P, Albanes D, Pietmen P. Intake of flavonoids, carotenoids, vitamins C and E, and risk of stroke in male smokers. Stroke 2000;31:2301-6.
9. Hirvonen T, Pietinen P, Virtanen M, et al Intake of flavonols and flavones and risk of coronary heart disease in male smokers. Epidemiology 2001;12:62-7.
10. Knekt P, Isotupa S, Rissanen H, et al. Quercetin intake and the incidence of cerebrovascular disease. Eur J Clin Nutr 2000;54:415-7
11. Keh SO, Hertog MG, Feskens EJ, Kromhout D. Dietary flavonoids, antsoxidant vitamins, and incidence of stroke: the Zutphen study. Arch Intern Med 1996;156:637-42.
12. Knekt P, Jarvinen R, Reunanen A, Maatela J. Flavonoid intake and coronary mortality in Finland: a cohort study. BMJ 1996;312:478-81
13. Hertog MG, Feskens EJ, Hollman PC, Katan MB, Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet 1993;342:1007-11.
14. Hertog MG, Feskens EJ, Kromhout D. Antioxidant flavonols and coronary heart disease risk. Lancet 1997;349:699 (letter).
15. Geleijnse JM, Launer LJ, Van der Kuip DA, Hofman A, Witteman JC. Inverse association of tea and flavonoid intakes with incident myocardial infarction: the Rotterdam Study. Am J Clin Nutr 2002;75:880-6.
16. Knekt P, Kumpulainen J, Jarvinen R, et al. Flavonoid intake and risk of chronic diseases. Am J Clin Nutr 2002;76:560-8.
17. Buring JE, Hennekens CH, for the Women's Health Study Research Group. The Women's Health Study: summary of the study design. J Myocardial Ischemia 1992;4:27-9.
18. Buring JE, Hennekens CH, for the Women's Health Study Research Group. The Women's Health Study: rationale and background. J Myocardial Ischemia 1992;4:30-40.
19. Rexrode KM, Lee IM, Cook NR, Hennekens CH, Buring JE. Baseline characteristics of participants in the Women's Health Study. J Womens Health Gend Based Med 2000;9:19-27.
20. Liu S, Manson JE, Lee IM, et al. Fruit and vegetable intake and risk of cardiovascular disease: the Women's Health Study. Am J Clin Nutr 2000;72:922-8.
21. Willett WC, Stampfer MJ. Total energy intake: implications for epidemiologic analyses. Am J Epidemiol 1986;124:17-27.
22. World Health Organization. Ischaemic heart disease registers: report of the Fifth Working Group, including a second revision of the operating protocol: Copenhagen, 26-29 April 1971. Copenhagen: Regional Office for Europe, World Health Organization, 1971.
23. Gaziano JM, Buring JE, Breslow JL, et al. Moderate alcohol intake, increased levels of high-density lipoprotein and its iubfractions, and decreased risk of myocardial infarction. N Engl J Med 1993;329: 1829-34.
24. Negre-Salvayre A, Salvayre R. Quercetin prevents the cytotoxicity of oxidized LDL on lymphoid cell lines. Free Radic Biol Med 1992;12:101-6.
25. Ho CT, Chen Q, Shi H, Zhang KQ, Rosen RT. Antioxidative effect of polyphenol extract prepared from various Chinese teas. Prev Med 1992;21:520-5.
26. Laughton MJ, Evans PJ, Moroney MA, Hoult JR, Halliwell B. Inhibition of mammalian 5-hpoxygenase and cyclo-oxygenase by flavonoids and phenolic dietary additives. Relationship to antioxidant activity and to iron ion-reducing ability. Biochem Pharmacol 1991; 42:1673-81.
27. Geleijnse JM, Witteman JC, Launer LJ, Lamberts SW. Pols HA. Tea and coronary heart disease: protection through estrogen-like activity? Arch Intern Med 2000;160:3328-9.
28. Rice-Evans CA, Miller NJ. Antioxidant activities of flavonoids as bioactive components of food. Biochem Soc Trans 1996;24:790-5.
29. Marchioli R, Schweiger C, Levantesi G, Tavazzi L, Valagussa F. Antioxidant vitamins and prevention of cardiovascular disease: epidemiological and clinical trial data. Lipids 2001;36(suppl):S53-63.
30. Stensvold I, Tverdal A, Solvoll K, Foss OP. Tea consumption, relationship to cholesterol, blood pressure, and coronary and total mortality. Prev Med 1992;21:546-53.
31. Kark JD, Friedlander Y, Kaufmann NA, Stein Y. Coffee, tea, and plasma cholesterol: the Jerusalem Lipid Research Clinic prevalence study. Br Med J (Clin Res Ed) 1985;291:699-704.
32. Klatsky AL, Petitti DB, Armstrong MA, Friedman GD. Coffee, tea and cholesterol. Am J Cardiol 1985;55:577-8.
33. Green MS, Harari G. Association of serum lipoproteins and health-related habits with coffee and tea consumption in free-living subjects examined in the Israeli CORDIS Study. Prev Med 1992;21:532-45.
34. Sesso HD, Gaziano JM, Buring JE, Hennekens CH. Coffee and tea intake and the risk of myocardial infarction. Am J Epidemiol 1999; 149:162-7.
35. Duffy SJ, Vita JA, Holbrook M, Swerdloff PL, Keaney JF Jr. Effect of acute and chronic tea consumption on platelet aggregation in patients with coronary artery disease. Arterioscler Thromb Vasc Biol 2001;21:1084-9.
36. Coffee drinking and acute myocardial infarction. Report from the Boston Collaborative Drug Surveillance Program. Lancet 1972;2: 1278-81.
37. Jick H, Miettinen OS, Neff RK, Shapiro S, Heinonen OP, Slone D. Coffee and myocardial infarction. N Engl J Med 1973;289:63-7.
38. Rosenberg L, Palmer JR, Kelly JP, Kaufman DW, Shapiro S. Coffee drinking and nonfatal myocardial infarction in men under 55 years of age. Am J Epidemiol 1988;128:570-8.
39. Geleijnse JM, Launer LJ, Hofman A, Pols HA, Witteman JC. Tea flavonoids may protect against atherosclerosis: the Rotterdam Study. Arch Intern Med 1999;159:2170-4.
40. Food and Drug Administration. Food labeling: health claims; soy protein and coronary heart disease. Final rule. Fed Regist 1999;64: 57700-33.
41. Erdman JW Jr. AHA Science Advisory: soy protein and cardiovascular disease: a statement for healthcare professionals from the Nutrition Committee of the AHA. Circulation 2000;102:2555-9.
42. Anderson JW, Johnstone BM, Cook-Newell ME. Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med 1995;333:276-82.
43. Lissin LW, Cooke JP. Phytoestrogens and cardiovascular health. J Am Coll Cardiol 2000;35:1403-10.
44. Kuhnau J. The flavonoids. A class of semi-essential food components: their role in human nutrition. World Rev Nutr Diet 1976;24:117-91.
45. Arts IC, van de Putte B, Hollman PC. Catechin contents of foods commonly consumed in The Netherlands. 1. Fruits, vegetables, staple foods, and processed foods. J Agric Food Chem 2000;48. 1746-51.
46. Arts IC, van De Putte B, Hollman PC. Catechin contents of foods commonly consumed in The Netherlands. 2. Tea, wine, fruit juices, and chocolate milk. J Agric Food Chem 2000;48:1752-7.
47. Arts IC, Hollman PC, Feskens EJ, Bueno de Mesquita HB, Kromhout D. Catechin intake might explain the inverse relation between tea consumption and ischemic heart disease: the Zutphen Elderly Study. Am J Clin Nutr 2001;74:227-32.
48. Gaziano JM, Manson JE, Branch LG, Colditz GA, Willett WC, Buring JE. A prospective study of consumption of carotenoids in fruits and vegetables and decreased cardiovascular mortality in the elderly. Ann Epidemiol 1995;5:255-60.